Interferon Gamma: all 65 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppressionRecruitingNCT06774235Phase 3
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingNCT06381661Phase 2
- Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU PatientsRecruitingNCT05843786Phase 3
- Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and TuberculosisCompletedNCT05065905Phase 1/2Results posted
- Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19CompletedNCT05054114Not applicableResults posted
- Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast CancerCompletedNCT03112590Phase 1/2Results posted
- Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial SarcomaCompletedNCT03063632Phase 2Results posted
- Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerTerminatedNCT02948426Phase 1Results posted
- Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's AtaxiaCompletedNCT02797080Phase 3Results posted
- ACTIMMUNE in Intermediate OsteopetrosisCompletedNCT02666768Phase 2Results posted
- Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia StudyCompletedNCT02593773Phase 3Results posted
- Use of ACTIMMUNE in Patients With ADO2CompletedNCT02584608Phase 2Results posted
- Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's AtaxiaCompletedNCT02415127Phase 3Results posted
- Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)TerminatedNCT02338973Phase 1/2Results posted
- Interferon Gamma-1b in Friedreich Ataxia (FRDA)CompletedNCT01965327Phase 2Results posted
- Recombinant Interferon Gamma in Treating Patients With Soft Tissue SarcomaTerminatedNCT01957709Early Phase 1Results posted
- Topical Interferon Gamma-1b for Central Serous ChorioretinopathyCompletedNCT01468337Phase 1/2Results posted
- Topical Interferon Gamma for Macular Edema Secondary to UveitisCompletedNCT01376362Phase 1/2Results posted
- Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous DiseaseTerminatedNCT01147042Phase 4Results posted
- Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerCompletedNCT00501644Phase 2Results posted
- Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the LungsCompletedNCT00201123Phase 2Results posted
- Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired PneumoniaCompletedNCT05395702Not applicable
- Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic ProstatitisCompletedNCT05378646Phase 3
- Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital WartsCompletedNCT05156541Phase 3
- Safety and Efficacy of Interferon-Gamma 1b in Patients With CandidemiaCompletedNCT04979052Phase 2
- Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP StudyStatus unknownNCT04793568Phase 2
- IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT04628338Early Phase 1
- Open Trail of γIFN for Friedreich AtaxiaCompletedNCT03888664Phase 2
- Combination of Interferon-gamma and Nivolumab for Advanced Solid TumorsCompletedNCT02614456Phase 1
- Effect of IFN-γ on Innate Immune CellsCompletedNCT02609932Phase 1
- DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain TumorsCompletedNCT02197169Phase 1
- A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA PatientsCompletedNCT02035020Phase 2
- Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy VolunteersStatus unknownNCT01929382Phase 1
- A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCTStatus unknownNCT01639261Phase 2
- Cell Responses to IFN-gammaTerminatedNCT01317017Early Phase 1
- The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon GammaCompletedNCT00943982Phase 1
- A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis BStatus unknownNCT00753467Phase 2
- Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-respondersCompletedNCT00538811Phase 2/3
- HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
- Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis CCompletedNCT00148863Phase 2
- Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex InfectionCompletedNCT00111397Phase 1
- An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPFTerminatedNCT00076635Phase 3
- The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT00075998Phase 3
- Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00070187Phase 2/3
- Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma PatientsTerminatedNCT00057447Phase 1/2
- An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00052052Phase 2
- A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
- A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047658Phase 2
- A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047645Phase 3
- Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal CancerTerminatedNCT00047632Phase 3
- Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC InfectionTerminatedNCT00043355Phase 2
- Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic FibrosisCompletedNCT00043342Phase 1/2
- Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic FibrosisCompletedNCT00043316Phase 1/2
- Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or CirrhosisCompletedNCT00043303Phase 2
- Gamma Interferon Therapy for Chronic Hepatitis CCompletedNCT00028275Phase 2
- Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal MeningitisCompletedNCT00012467Phase 2
- Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital OsteopetrosisCompletedNCT00004402Phase 3
- Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid TumorsCompletedNCT00004016Phase 1
- The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDSCompletedNCT00002433Not applicable
- Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type ICompletedNCT00001905Phase 2
- Interferon Gamma for Drug Resistant TuberculosisCompletedNCT00001407Phase 2
- Treatment of Non-Tuberculous Mycobacterial Infections With Interferon GammaCompletedNCT00001318Phase 2
- A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of ChildhoodCompletedNCT00001317Phase 4
- A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity MelanomaCompletedNCT00001296Phase 3
- Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected ChildrenCompletedNCT00000761Phase 1